Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
1.800
-0.030 (-1.64%)
Apr 21, 2026, 10:22 AM EDT - Market open
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $50.47 million as of April 21, 2026. Its market cap has increased by 37.15% in one year.
Market Cap
50.47M
Enterprise Value
48.10M
1-Year Change
37.15%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.90M to $50.47M, a decrease of -68.24%. That is a compound annual growth rate of -12.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 51.30M | 68.20% |
| Dec 31, 2025 | 30.50M | -38.76% |
| Dec 31, 2024 | 49.80M | 260.87% |
| Dec 29, 2023 | 13.80M | 27.78% |
| Dec 30, 2022 | 10.80M | -78.82% |
| Dec 31, 2021 | 51.00M | 20.57% |
| Dec 31, 2020 | 42.30M | 166.04% |
| Dec 31, 2019 | 15.90M | 28.23% |
| Dec 31, 2018 | 12.40M | -92.01% |
| Dec 29, 2017 | 155.10M | -2.39% |
| Jun 29, 2017 | 158.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kezar Life Sciences | 54.15M |
| Mereo BioPharma Group | 53.73M |
| Edesa Biotech | 52.69M |
| Nutriband | 52.27M |
| Radiopharm Theranostics | 52.23M |
| Hyperion DeFi | 50.81M |
| Atossa Therapeutics | 50.20M |
| Telomir Pharmaceuticals | 49.85M |